Sharjah Electricity, Water and Gas Authority (SEWA) has completed the first phase of its water control and monitoring system, a key strategic project in ...
On the PV side, the ESA Series supports a maximum MPPT current of 20A, enabling compatibility with higher-capacity solar modules. With 200% PV oversizing capability, the system captures more ...
Emirates News Agency on MSN
SEWA launches power, water networks in Wadi Al Helo
SHARJAH, 21st February, 2026 (WAM) -- Sharjah Electricity, Water and Gas Authority (SEWA) has completed the operation of electricity and water distribution networks and connected services to the ...
High-Precision Invisible Protection for Multi-Pet Households via Dual-Frequency Tech Seamless Indoor-Outdoor Coverage ...
AVIA Property Unveils 2026 Strategy, Celebrates Two Decades of Growth with Launch of "The Park Lane 15"; Targets Over 266 Million Baht in Transfers with 15% Growth ...
The City of San Diego is looking to roll out new parking meters in the mid-city neighborhoods, including Normal Heights and Kensington-Talmadge. Lady Gaga brings mayhem back to Grammys with ...
Altimmune closed a $75M direct offering to fund Phase 3 pemvidutide trials for MASH, leveraging recent positive Phase 2b data and FDA Breakthrough Therapy status. Pemvidutide’s dual GLP-1/glucagon ...
Rohan Naahar is a Weekend News Writer for Collider. From Francois Ozon to David Fincher, he'll watch anything once. He has covered everything from Marvel to the Oscars, and Marvel at the Oscars. He ...
MSD and Daiichi Sankyo have revealed some of the clinical data that prompted them to start pivotal testing of ifinatamab deruxtecan (I-DXd) in patients with previously treated, extensive-stage small ...
Emerson's SmartVoice line lets you order devices around without the need for apps or the internet. I found out how well it ...
A creatine loading phase uses 20 to 25 grams daily for 5 to 7 days to quickly saturate muscle creatine stores, then shifts to 3 to 5 grams daily. Research suggests loading can raise muscle creatine ...
Eli Lilly's latest clinical readout for dual GIP/GLP-1 agonist tirzepatide is a big one, with data suggesting the drug can reduce the risk of developing type 2 diabetes in overweight and obese adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results